Skip to Main Content
Welcome to the Marketplace

Go to Main Navigation


Boston, MA, US
Company Type:
Small Business (1-10M TTM Revenue)

Abcodia is a clinical stage company engaged in the commercial development of novel, scientifically validated tests for the early detection of cancer. The Company’s first product is the ROCA® Test for the early detection of ovarian cancer. It is also expanding its pipeline of early detection technologies for lung, colorectal and pancreatic cancer.
Our products are based on expertise in measuring and modelling dynamic changes over time of serum-based biomarkers before cancer is clinically diagnosed and it maintains exclusive commercial access to a biobank of prospectively collected samples donated from over 200,000 individuals over a 10-year period.
We hold strategic collaborations with leading global organizations including Cancer Research UK, University College London and other academic and industry partners.
Abcodia is a privately held company funded through investments from Albion Ventures, Cambridge Innovative Capital plc, Scottish Equity Partners and UCL Business Plc. Headquartered in Cambridge, U.K., the Company maintains a U.S. corporate presence in Boston.

Site Badges
Cambourne, England, CB23 6DP United Kingdom
745 Atlantic Avenue Boston, MA, 02111 United States
3495 Hacks Cross Road Memphis, TN, 38125 United States

Get started

To request access, simply fill out the form below and we will contact you.

Password must:

• Be at least 12 characters in length

• Contain a lowercase letter (a-z)

• Contain an uppercase letter (A-Z)

• Contain a numeral (0-9)

• Contain a special character (%, $, !, @)

By signing up for this account you agree to the Terms of Service